| ALT | 8-K | neutral | 3/10 | Altimmune drew $10.0 million (Tranche Three) from its existing $125.0 million loan facility with Hercules Capital, trigg | Oct 29, 2026 |
| LTH | 8-K | bullish | 6/10 | Life Time reported Q3 2026 revenue of $893.5M (+14.2% YoY) and diluted EPS of $0.46 (+2.2% YoY), both above consensus es | Oct 29, 2026 |
| CCC | PRESS-RELEASE | bullish | 6/10 | CCC reported Q3 2026 revenue of $294.1M (up 10.1% YoY) and GAAP diluted EPS of $0.05, beating the consensus estimate of | Oct 29, 2026 |
| MYE | 8-K | bearish | 5/10 | Myers Industries reported Q3 2026 net sales of $171.3M, up 8.1% YoY, but GAAP EPS from continuing operations fell to $0. | Oct 29, 2026 |
| PHAT | 8-K | bullish | 6/10 | Phathom Pharmaceuticals reported Q3 2026 net revenue of $84.7M, up 71% YoY and 14% sequentially, and generated positive | Oct 29, 2026 |
| MO | 8-K | neutral | 5/10 | Altria reported Q3 2026 adjusted diluted EPS of $1.52, in line with the $1.51 consensus, on net revenues of $6.13B (abov | Oct 29, 2026 |
| TSAT | 6-K | bearish | 6/10 | Telesat reported a net loss of $157.2M for Q3 2026 (vs. $121.1M loss in Q3 2025) and $866.7M for 9M 2026 (vs. $97.0M los | Oct 29, 2026 |
| INCY | 8-K | bullish | 6/10 | Incyte reported Q3 2026 total revenue of $1.56B (+14% YoY) and total net sales of $1.32B (+14% YoY), with Jakafi net sal | Oct 29, 2026 |
| NCLH | 8-K | neutral | 3/10 | Norwegian Cruise Line Holdings Ltd. announced the planned retirement of CFO Mark Kempa effective June 30, 2027, with a t | Oct 29, 2026 |
| CDLR | 425 | neutral | 5/10 | Cadeler A/S announced plans to suspend trading of its shares on the Oslo Stock Exchange effective on or around November | Oct 29, 2026 |
| LLY | 8-K | bullish | 6/10 | Lilly reported Q3 2026 revenue of $24.4B (+39% YoY) and non-GAAP EPS of $7.48 (+7% YoY), beating consensus estimates of | Oct 29, 2026 |
| PGY | 8-K | bullish | 6/10 | Pagaya reported record Q3 2026 GAAP net income of $50M, up 121% YoY, with network volume of $3.6B (+29% YoY) and total r | Oct 29, 2026 |
| ASPS | 8-K | neutral | 5/10 | Altisource reported Q3 2026 service revenue of $49.8M, up 26% YoY, and Adjusted EBITDA of $4.3M, up 17% YoY. The company | Oct 29, 2026 |
| BAND | 8-K | bullish | 6/10 | Bandwidth reported Q3 2026 revenue of $234M (up 22% YoY), Adjusted EBITDA of $35M (up 43% YoY), and raised full-year 202 | Oct 29, 2026 |
| CROX | 8-K | bullish | 6/10 | Crocs reported Q3 2026 revenue of $1.043B (up 4.6% YoY) and adjusted EPS of $3.69, beating the $3.31 consensus. Full-yea | Oct 29, 2026 |
| TSAT | PRESS-RELEASE | bearish | 6/10 | Telesat reported Q3 2026 revenue of $81M, down 20% YoY, and adjusted EBITDA of $12M, down 74% YoY. The company reiterate | Oct 29, 2026 |
| SIRI | PRESS-RELEASE | neutral | 4/10 | The results show no surprise versus expectations, and the press release does not include any guidance change or material | Oct 29, 2026 |
| ENTG | 8-K | bullish | 6/10 | Entegris reported record Q3 2026 revenue of $1.0057B, up 24.6% YoY, with GAAP EPS of $1.03 and non-GAAP EPS of $1.23, bo | Oct 29, 2026 |
| INSM | 8-K | bullish | 6/10 | Insmed reported Q3 2026 total revenue of $524.4M, beating the $499.5M consensus, driven by BRINSUPRI sales of $400.1M (u | Oct 29, 2026 |
| HIPO | PRESS-RELEASE | bullish | 6/10 | Hippo Holdings reported Q3 2026 adjusted EPS of $0.74, beating the $0.49 consensus by 51.0%, and revenue of $156M, beati | Oct 29, 2026 |
| INDV | PRESS-RELEASE | neutral | 5/10 | Indivior reported Q3 2026 total net revenue of $356M (up 13% YoY) and GAAP diluted EPS of $1.12, above the $329.4M reven | Oct 29, 2026 |
| ALGM | PRESS-RELEASE | bullish | 6/10 | Allegro MicroSystems reported Q2 fiscal 2027 results with revenue of $277M (up 29% YoY) and non-GAAP EPS of $0.26 (up 10 | Oct 29, 2026 |
| FNWB | PRESS-RELEASE | bearish | 6/10 | First Northwest Bancorp reported a net loss of $743,000 ($0.08 per share) for Q3 2026, compared to net income of $308,00 | Oct 29, 2026 |
| TW | 8-K | bullish | 6/10 | Tradeweb Q3 2026 revenue of $584.5M (+14.9% YoY) and adjusted diluted EPS of $1.02 (+17.2% YoY) beat consensus estimates | Oct 29, 2026 |
| HII | PRESS-RELEASE | bullish | 6/10 | HII reported Q3 2026 revenue of $3.537B, up 10.8% YoY and above the $3.37B consensus, and diluted EPS of $5.48, beating | Oct 29, 2026 |
| PHAT | PRESS-RELEASE | bullish | 5/10 | Phathom Pharmaceuticals reported Q3 2026 net revenue of $84.7M, up 71% YoY and above the $84.8M consensus (essentially i | Oct 29, 2026 |
| TPG | 8-K | bullish | 6/10 | TPG reported Q3 2026 Fee-Related Earnings of $321M, up 43% YoY, and After-tax Distributable Earnings of $265M, up 24% Yo | Oct 29, 2026 |
| FMBH | 8-K, 425 | neutral | 6/10 | First Mid Bancshares, Inc. (FMBH) announced the acquisition of Evergreen Bancshares, Inc. (parent of American Bank of Fr | Oct 29, 2026 |
| FMBH | 8-K | neutral | 5/10 | First Mid Bancshares reported Q3 2026 GAAP net income of $33.3 million ($1.25 diluted EPS), a record high, compared to $ | Oct 29, 2026 |
| LGND | PRESS-RELEASE | bullish | 6/10 | Ligand Pharmaceuticals reported Q3 2026 adjusted EPS of $2.67, beating the $2.33 consensus by 14.6%. Royalty revenue sur | Oct 29, 2026 |